$IRIX News

Iridex Announces the Publication of Two-Year Independent Study Supporting Benefits of MicroPulse® Technology for Early to Advanced Glaucoma

Iridex Announces Publication Of 2-Yr Clinical Study Demonstrating Favorable Outcomes With TLT Using MicroPulse Technology In Patients With Primary Glaucoma

Iridex Completes Relocation of Manufacturing Facility to San Jose, California

IRIDEX (IRIX) Q2 2026 Earnings Call Transcript

IRIDEX Q2 Loss Widens Y/Y as Retina Weakness Weighs, Stock Down 15%

IRIDEX Corp (IRIX) (Q2 2026) Earnings Call Highlights: Cyclo-G6 Surges 35% as Company Achieves ...

IRIDEX Corporation Q2 2026 Earnings Call Summary

Iridex Reports Second Quarter 2026 Financial Results

IRIDEX Corporation (IRIX) Q2 2026 Earnings Call Transcript

Full Transcript: Iridex Q2 2026 Earnings Call

Iridex Affirms FY2026 Sales Guidance of $51.000M-$53.000M vs $53.227M Est

Iridex Q2 EPS $(0.07) Misses $(0.01) Estimate, Sales $12.566M Miss $13.587M Estimate

Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026

Iridex Adds EndoProbe® Handpieces to EyeProGPO Product Offering

Iridex Expands Its EyeProGPO Product Offering To Include The Company’s Line Of EndoProbe Handpieces

Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference

IRIX Stock Up 4% As Q1 Loss Narrows Y/Y on Glaucoma Product Growth

IRIDEX Corp (IRIX) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ...

IRIDEX Corporation Q1 2026 Earnings Call Summary

Iridex Corp (NASDAQ:IRIX) Q1 Loss Narrower Than Expected, Glaucoma Portfolio Strengthens